SAMHD1 and Aicardi-Goutieres syndrome 5: Although Aicardi-Goutières syndrome type 5 (AGS5) has historically been characterized by hallmark neuroimaging findings and central nervous system involvement, recent reports have expanded the phenotypic landscape of SAMHD1 deficiency to include diverse systemic, cutaneous and rheumatologic manifestations [4, 5].